Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT00935233
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Prior or current diagnosis of pure ductal carcinoma in situ (DCIS)
* Age ≤ 60 years at the time of diagnosis
* DCIS with contralateral synchronous or asynchronous invasive breast cancer is permitted
* DCIS associated with microinvasion (foci \< 1 mm) is permitted
* Healthy age- and ethnicity-matched controls
* No history of DCIS
* No relative (up to second degree) diagnosed with DCIS
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* Not specified
Healthy Volunteers:
True
Sex:
FEMALE
Study:
NCT00935233
Study Brief:
Protocol Section:
NCT00935233